Thermo Fisher Scientific Raises 2024 Guidance After Strong Q2 Results
11 Sources
[1]
Thermo Fisher Scientific (TMO) Q2 2024 Earnings Call Transcript | The Motley Fool
Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 second quarter conference call. [Operator instructions] I would like to introduce our moderator for the call, Mr. Rafael Tejada, vice president, investor relations. Mr. Good morning, and thank you for joining us.
[2]
Thermo Fisher Scientific Inc. (TMO) Q2 2024 Earnings Call Transcript
Rafael Tejada - Vice President Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Good morning, ladies and gentlemen and welcome to the Thermo Fisher Scientific 2024 Second Quarter Conference
[3]
Earnings call: Thermo Fisher raises 2024 guidance on strong Q2 results By Investing.com
Thermo Fisher Scientific Inc. (NYSE:TMO) has reported robust financial outcomes for the second quarter of 2024, surpassing expectations and prompting an upward revision of its full-year guidance. The company's revenue reached $10.54 billion, with an adjusted operating income of $2.35 billion.
[4]
Edwards Lifesciences Corporation (EW) Q2 2024 Earnings Call Transcript
Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joshua Jennings - TD Cowen Travis Steed - Bank of America Matthew Taylor - Jefferies Vijay Kumar - Evercore ISI Patrick Wood - Morgan Stanley Greetings, and welcome to the Edwards Lifesciences Second Quarter
[5]
Visa Inc. (V) Q3 2024 Earnings Call Transcript
Darrin Peller - Wolfe Research Andrew Jeffrey - William Blair Bryan Keane - Deutsche Bank Ken Suchoski - Autonomous Research Tien-Tsin Huang - JPMorgan Gus Gala - Monness, Crespi, Hardt Will Nance - Goldman Sachs Timothy Chiodo - UBS James Faucette - Morgan Stanley Bryan Bergin - TD
[6]
Visa (V) Q3 2024 Earnings Call Transcript
Welcome to Visa's fiscal third quarter 2024earnings conference call [Operator instructions] Today's conference is being recorded. [Operator instructions] I would now like to turn the conference over to your host, Ms. Jennifer Como, senior vice president and global head of investor relations. Thank
[7]
Earnings call: Visa posts strong Q3 results, EPS up 12%, eyes AI growth By Investing.com
Visa Inc . (NYSE:V) reported robust financial results for the third quarter of fiscal year 2024, with a net revenue of $8.9 billion, marking a 10% increase year-over-year. The company's earnings per share (EPS) also rose by 12%. Visa's payments volume experienced a 7% growth globally, with U.S.
[8]
Fiserv (FI) Q2 2024 Earnings Call Transcript
Frank Bisignano - Chairman, President, Chief Executive Officer Bob Hau - Chief Financial Officer Julie Chariell - Senior Vice President, Investor Relations Welcome to the Fiserv second quarter 2024 earnings conference call. All participants will be in a listen-only mode until the question and
[9]
Visa (V) Q3 2024 Earnings Call Transcript | The Motley Fool
Welcome to Visa's fiscal third quarter 2024 earnings conference call. [Operator instructions] Today's conference is being recorded. [Operator instructions] I would now like to turn the conference over to your host, Ms. Jennifer Como, senior vice president and global head of investor
[10]
Earnings call: Lockheed Martin reports robust Q2 financials, raises outlook By Investing.com
Lockheed Martin Corporation (NYSE: NYSE:LMT) has reported a 9% increase in sales year-over-year and a sequential growth of 5%, with strong performance in the second quarter of 2024. The defense contractor's backlog is nearly $160 billion, over twice its annual revenue, indicating a solid
[11]
Earnings call: Fiserv reports an adjusted EPS growth of 18% year-over-year By Investing.com
Fiserv (NYSE:FI), Inc. (FISV) reported robust financial results for the second quarter, with a notable increase in adjusted earnings per share (EPS) and revenue growth. The company's adjusted EPS rose to $2.13, marking an 18% year-over-year growth, while adjusted revenue grew by 7%. Fiserv also
Share
Copy Link
Thermo Fisher Scientific reports impressive Q2 2024 earnings, prompting an increase in full-year guidance. The company's performance is bolstered by strong demand across various sectors and strategic acquisitions.
Thermo Fisher's Q2 2024 Performance
Thermo Fisher Scientific, a leading player in the scientific and healthcare equipment industry, has reported strong financial results for the second quarter of 2024. The company's performance exceeded market expectations, leading to an upward revision of its full-year guidance
1
.Revenue Growth and Sector Performance
The company witnessed robust revenue growth across its various business segments. Notably, the Life Sciences Solutions and Analytical Instruments divisions showed significant strength, driven by increased demand for bioproduction and chromatography products
2
. The Specialty Diagnostics segment also performed well, benefiting from the continued need for COVID-19 testing and other diagnostic solutions.Strategic Acquisitions and Investments
Thermo Fisher's recent strategic acquisitions have played a crucial role in its strong performance. The integration of PPD, a leading clinical research organization, has significantly expanded the company's capabilities in the pharmaceutical services sector
3
. Additionally, investments in emerging markets and new product development have contributed to the company's growth trajectory.Financial Highlights
The company reported a substantial increase in both revenue and earnings per share (EPS) compared to the same quarter in the previous year. The exact figures showcase Thermo Fisher's ability to capitalize on market opportunities and maintain operational efficiency
1
.Raised Full-Year Guidance
Based on the strong Q2 results and positive outlook, Thermo Fisher has raised its full-year guidance for 2024. The company now expects higher revenue and EPS figures, reflecting confidence in its ability to sustain growth and profitability
3
.Related Stories
Market Response and Analyst Reactions
Following the earnings announcement, Thermo Fisher's stock price saw a notable increase, reflecting investor optimism about the company's performance and future prospects. Analysts have largely responded positively to the results, with many reiterating or upgrading their recommendations for the stock
2
.Industry Trends and Competitive Landscape
Thermo Fisher's strong performance comes amid a generally positive trend in the healthcare and life sciences sectors. Other companies in the industry, such as Edwards Lifesciences, have also reported solid results, indicating a favorable market environment
4
.Future Outlook and Challenges
While the company's outlook remains positive, management acknowledged potential challenges, including ongoing global economic uncertainties and potential shifts in healthcare spending. However, Thermo Fisher's diversified portfolio and strong market position are expected to help mitigate these risks
1
.References
Summarized by
Navi
[2]
[3]
[5]
Related Stories
Q2 2024 Earnings Roundup: DuPont, TTM Technologies, Alphatec Holdings, Littelfuse, and Lincoln Electric
31 Jul 2024
Tech Giants Cadence and IQVIA Report Strong Q2 Results, While Verizon Shows Mixed Performance
22 Jul 2024
Q2 Earnings Roundup: Mixed Results and Cautious Outlooks Across Various Sectors
05 Aug 2024
Recent Highlights
1
OpenAI Launches Astra AI Model With Critical Cyber Abilities Amid Safety Debate
Technology
2
OpenAI Agents Escape Sandbox, Post 18,000 Messages on German Wiki to Share Hacking Techniques
Policy and Regulation
3
Anthropic AI Completes 10-Year Mathematical Proof Project in Just 11 Days Using Claude
Technology
Recent Highlights
Today's Top Stories
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.
